Beverley Hammond

581 total citations
11 papers, 418 citations indexed

About

Beverley Hammond is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Beverley Hammond has authored 11 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Organic Chemistry and 3 papers in Molecular Biology. Recurrent topics in Beverley Hammond's work include Inflammatory mediators and NSAID effects (4 papers), Synthesis and Biological Evaluation (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Beverley Hammond is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Synthesis and Biological Evaluation (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Beverley Hammond collaborates with scholars based in United Kingdom. Beverley Hammond's co-authors include David J. Spalding, Alexander J. Stevens, Sac-Pham Tang, Leanne Cutler, Phil Jeffrey, Anne Hersey, Scott Summerfield, Vahn A. Lewis, Ivan L. Pinto and Colin H. Macphee and has published in prestigious journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and Behavioural Brain Research.

In The Last Decade

Beverley Hammond

11 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beverley Hammond United Kingdom 9 145 96 91 89 67 11 418
Maria Ribadeneira United States 14 265 1.8× 124 1.3× 59 0.6× 191 2.1× 26 0.4× 27 839
Mark E. McDonnell United States 14 186 1.3× 56 0.6× 83 0.9× 107 1.2× 44 0.7× 31 509
Claudia Keller Switzerland 17 217 1.5× 159 1.7× 78 0.9× 51 0.6× 16 0.2× 34 495
Tamara L. Casebolt United States 9 334 2.3× 123 1.3× 59 0.6× 67 0.8× 21 0.3× 11 614
Kazunobu Aoyama Japan 14 199 1.4× 73 0.8× 72 0.8× 83 0.9× 49 0.7× 19 409
Justin Ansell United States 11 190 1.3× 73 0.8× 65 0.7× 81 0.9× 35 0.5× 14 486
Jurema Schmidt Germany 15 222 1.5× 85 0.9× 36 0.4× 105 1.2× 26 0.4× 28 499
Andrew D. Gribble United Kingdom 14 362 2.5× 177 1.8× 41 0.5× 131 1.5× 71 1.1× 20 674
Marie‐Anne Peyronneau France 18 260 1.8× 159 1.7× 70 0.8× 236 2.7× 21 0.3× 34 848
Duncan Armstrong United Kingdom 13 279 1.9× 141 1.5× 38 0.4× 31 0.3× 89 1.3× 20 744

Countries citing papers authored by Beverley Hammond

Since Specialization
Citations

This map shows the geographic impact of Beverley Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverley Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverley Hammond more than expected).

Fields of papers citing papers by Beverley Hammond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverley Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverley Hammond. The network helps show where Beverley Hammond may publish in the future.

Co-authorship network of co-authors of Beverley Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Beverley Hammond. A scholar is included among the top collaborators of Beverley Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverley Hammond. Beverley Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ward, Richard A., Ambra Bianco, Nicola Colclough, et al.. (2019). Abstract 4813: Comparative activity profiling of tyrosine kinase inhibitors (TKIs) against exon 20 insertions and the wild-type form of epidermal growth factor receptor (EGFR). Cancer Research. 79(13_Supplement). 4813–4813. 1 indexed citations
2.
Critchlow, Susan E., Gareth Hughes, Anna D. Staniszewska, et al.. (2019). Abstract 1207: Reversing lactate-driven immunosuppression using the novel, potent and selective MCT4 inhibitor AZD0095. Cancer Research. 79(13_Supplement). 1207–1207. 5 indexed citations
3.
Waters, Kerry A., Tania O. Stean, Beverley Hammond, et al.. (2011). Effects of the selective 5-HT7 receptor antagonist SB-269970 in animal models of psychosis and cognition. Behavioural Brain Research. 228(1). 211–218. 48 indexed citations
4.
Hall, Adrian, Susan H. Brown, Iain P. Chessell, et al.. (2006). 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure–activity relationships of 4- and 5-substituted benzoic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 17(3). 732–735. 9 indexed citations
5.
Hall, Adrian, Stephen J. Atkinson, Susan H. Brown, et al.. (2006). Structure–activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3657–3662. 21 indexed citations
6.
Summerfield, Scott, Alexander J. Stevens, Leanne Cutler, et al.. (2006). Improving the in Vitro Prediction of in Vivo Central Nervous System Penetration: Integrating Permeability, P-glycoprotein Efflux, and Free Fractions in Blood and Brain. Journal of Pharmacology and Experimental Therapeutics. 316(3). 1282–1290. 138 indexed citations
7.
Hall, Adrian, Susan H. Brown, Iain P. Chessell, et al.. (2006). 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure–activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 17(4). 916–920. 12 indexed citations
8.
9.
Bloomer, Jackie C., Murray J. B. Brown, Hung‐Yuan Cheng, et al.. (2003). The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 13(6). 1067–1070. 100 indexed citations
10.
Bloomer, Jackie C., Murray J. B. Brown, Hung‐Yuan Cheng, et al.. (2002). The discovery of SB-435495. Bioorganic & Medicinal Chemistry Letters. 12(18). 2603–2606. 34 indexed citations
11.
Boyd, Helen, Beverley Hammond, Robert J. Ife, et al.. (2001). The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 11(5). 701–704. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Ribadeneira Breakdown of academic impact, for papers by Mark E. McDonnell Breakdown of academic impact, for papers by Claudia Keller Breakdown of academic impact, for papers by Tamara L. Casebolt Breakdown of academic impact, for papers by Kazunobu Aoyama Breakdown of academic impact, for papers by Justin Ansell Breakdown of academic impact, for papers by Jurema Schmidt Breakdown of academic impact, for papers by Andrew D. Gribble Breakdown of academic impact, for papers by Marie‐Anne Peyronneau Breakdown of academic impact, for papers by Duncan Armstrong
Rankless by CCL
2026